| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Nov 21, 2025 | Dec 18, 2025 | Keros Therapeutics, Inc. | Director | Sell | 16.3 | -322,021 | -55.45% | ✗ | $5.7M |
| Apr 13, 2020 | Jan 20, 2023 | Keros Therapeutics, Inc. | Director | Buy | 61.3 | +1,191 | 0.21% | ✗ | $25K |
| Jan 3, 2022 | Jan 5, 2022 | Keros Therapeutics, Inc. | Director | Sell | 42.5 | -47,651 | -0.67% | ✓ | $2.8M |
| Dec 1, 2021 | Dec 3, 2021 | Keros Therapeutics, Inc. | Director | Sell | 42.5 | -47,651 | -0.92% | ✓ | $2.6M |
| Nov 1, 2021 | Nov 3, 2021 | Keros Therapeutics, Inc. | Director | Sell | 40.0 | -47,651 | -1.14% | ✓ | $2M |
| Oct 19, 2021 | Oct 21, 2021 | Keros Therapeutics, Inc. | Director | Sell | 46.3 | -8,598 | -0.30% | ✓ | $328.4K |
| Oct 14, 2021 | Oct 18, 2021 | Keros Therapeutics, Inc. | Director | Sell | 42.5 | -26,367 | -0.59% | ✓ | $1M |
| Oct 1, 2021 | Oct 5, 2021 | Keros Therapeutics, Inc. | Director | Sell | 45.0 | -12,686 | -0.56% | ✓ | $508.8K |
| Sep 27, 2021 | Sep 29, 2021 | Keros Therapeutics, Inc. | Director | Sell | 32.5 | -95,302 | -3.88% | ✓ | $3.9M |
| Jul 1, 2021 | Jul 6, 2021 | Keros Therapeutics, Inc. | Director | Sell | 40.0 | -47,652 | -1.08% | ✓ | $2M |
| Jun 4, 2021 | Jun 8, 2021 | Keros Therapeutics, Inc. | Director | Sell | 46.3 | -19,415 | -0.26% | ✓ | $952.6K |
| Jun 1, 2021 | Jun 3, 2021 | Keros Therapeutics, Inc. | Director | Sell | 43.8 | -28,236 | -0.30% | ✓ | $1.4M |
| May 3, 2021 | May 5, 2021 | Keros Therapeutics, Inc. | Director | Sell | 42.5 | -47,651 | -0.70% | ✓ | $2.7M |
| Apr 6, 2021 | Apr 8, 2021 | Keros Therapeutics, Inc. | Director | Sell | 46.3 | -9,298 | -0.31% | ✓ | $546.8K |
| Apr 1, 2021 | Apr 5, 2021 | Keros Therapeutics, Inc. | Director | Sell | 42.5 | -38,353 | -0.53% | ✓ | $2.3M |
| Mar 3, 2021 | Mar 5, 2021 | Keros Therapeutics, Inc. | Director | Sell | 43.8 | -23,959 | -0.25% | ✓ | $1.4M |
| Mar 1, 2021 | Mar 3, 2021 | Keros Therapeutics, Inc. | Director | Sell | 45.0 | -23,690 | -0.18% | ✓ | $1.4M |
| Feb 16, 2021 | Feb 18, 2021 | Keros Therapeutics, Inc. | Director | Sell | 45.0 | -28,617 | -0.18% | ✓ | $1.7M |
| Feb 11, 2021 | Feb 16, 2021 | Keros Therapeutics, Inc. | Director | Sell | 45.0 | -19,029 | -0.15% | ✓ | $1.2M |